The Influence of High‐Efficiency Particulate Air Filtration on Mortality and Fungal Infection among Highly Immunosuppressed Patients: A Systematic Review
1Institute of Hygiene and Environmental Medicine, Charité–University Medicine Berlin, Berlin, and 2Institute of Microbiology and Hospital Hygiene, Medical University Hanover, Hanover, Germany
Background.
Patients with hematological malignancies who are treated with intensive chemotherapy or who receive bone marrow transplants are exposed to an increased risk of developing nosocomial fungal infections. The aim of this systematic review was to compare the effectiveness of high‐efficiency particulate air (HEPA) filtration with that of non‐HEPA filtration in decreasing the rates of mortality and fungal infection among patients with diagnosed hematological malignancies and neutropenia or among patients with bone marrow transplants.
Methods.
Articles identified in a Medline search, guidelines, and books, as well as the bibliographies of review articles, monographs, and the articles identified by Medline, were researched. Randomized trials and observational studies comparing HEPA filtration with conventional room ventilation were selected for inclusion in the present review.
Results.
Sixteen trials (9 with death as an outcome and 10 with fungal infection as an outcome) that compared HEPA filtration with non‐HEPA filtration were selected for meta‐analyses. We discovered no significant advantages of HEPA filtration in the prevention of death among patients with hematological malignancies with severe neutropenia in randomized controlled trials (RCTs; relative risk [RR], 0.86 [95% confidence interval {CI}, 0.65–1.14]) and in studies of a lower standard (non‐RCTs; RR, 0.87 [95% CI, 0.60–1.25]).
Conclusions.
The placement in protected areas of patients with hematological malignancies with severe neutropenia or patients with bone marrow transplants appears to be beneficial, but no definitive conclusion could be drawn from the data available.
Received 22 July 2005; accepted 16 December 2005; electronically published 13 April 2006.
Cited by
Online publication date: 18-Jun-2009.
CrossRef
Online publication date: 1-Jun-2009.
CrossRef
Online publication date: 3-May-2009.
CrossRef
Online publication date: 1-Jul-2008.
CrossRef
Online publication date: 1-Jun-2008.
CrossRef
Online publication date: 13-Apr-2007.
CrossRef
Online publication date: 1-Feb-2007.
CrossRef
Online publication date: 1-Dec-2006.
Online publication date: 1-Dec-2006.
-
Potential conflicts of interest: none reported.
This study was performed within the framework of the Hospital in Europe Link for Infection Control through Surveillance 3 Project (organized by Professor J. Fabry, Lyon, France), supported by the European Community.





